Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicja Sznarkowska

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancers|May 8, 2020
MHC Class I Regulation: The Origin PerspectiveAlicja Sznarkowska, Sara Mikac, Magdalena Pilch
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 23, 2010
[Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer]Alicja Sznarkowska, Robert Olszewski, Joanna Zawacka-Pankau
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 17, 2010
[The structure and cellular regulation of p73: their implication in anticancer therapy]Joanna Zawacka-Pankau, Katarzyna Maleńczyk, Alicja Sznarkowska
Oncotarget|December 3, 2016
Inhibition of cancer antioxidant defense by natural compoundsAlicja Sznarkowska, Anna Kostecka, Katarzyna Meller, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2010
p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?Joanna Zawacka-Pankau, Anna Kostecka, Alicja Sznarkowska, et al.
Cell Division|January 4, 2019
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in <i>TP</i>53-deficient cancer cellsAlicja Sznarkowska, Anna Kostecka, Anna Kawiak, et al.
FEBS Letters|December 15, 2010
Targeting of p53 and its homolog p73 by protoporphyrin IXAlicja Sznarkowska, Katarzyna Maleńczyk, Leszek Kadziński, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2019
Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis BMagda Rybicka, Anna Woziwodzka, Tomasz Romanowski, et al.
Cell Division|September 6, 2019
Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in <i>TP</i>53-deficient cancer cellsAlicja Sznarkowska, Anna Kostecka, Anna Kawiak, et al.
Molecular Genetics & Genomic Medicine|August 24, 2019
TNF-α polymorphisms affect persistence and progression of HBV infectionAnna Woziwodzka, Magda Rybicka, Alicja Sznarkowska, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancers|May 8, 2020
MHC Class I Regulation: The Origin PerspectiveAlicja Sznarkowska, Sara Mikac, Magdalena Pilch
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 23, 2010
[Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer]Alicja Sznarkowska, Robert Olszewski, Joanna Zawacka-Pankau
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 17, 2010
[The structure and cellular regulation of p73: their implication in anticancer therapy]Joanna Zawacka-Pankau, Katarzyna Maleńczyk, Alicja Sznarkowska
Oncotarget|December 3, 2016
Inhibition of cancer antioxidant defense by natural compoundsAlicja Sznarkowska, Anna Kostecka, Katarzyna Meller, et al.
Cell Cycle (Georgetown, Tex.)|February 18, 2010
p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?Joanna Zawacka-Pankau, Anna Kostecka, Alicja Sznarkowska, et al.
Cell Division|January 4, 2019
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in <i>TP</i>53-deficient cancer cellsAlicja Sznarkowska, Anna Kostecka, Anna Kawiak, et al.
FEBS Letters|December 15, 2010
Targeting of p53 and its homolog p73 by protoporphyrin IXAlicja Sznarkowska, Katarzyna Maleńczyk, Leszek Kadziński, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 11, 2019
Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis BMagda Rybicka, Anna Woziwodzka, Tomasz Romanowski, et al.
Cell Division|September 6, 2019
Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in <i>TP</i>53-deficient cancer cellsAlicja Sznarkowska, Anna Kostecka, Anna Kawiak, et al.
Molecular Genetics & Genomic Medicine|August 24, 2019
TNF-α polymorphisms affect persistence and progression of HBV infectionAnna Woziwodzka, Magda Rybicka, Alicja Sznarkowska, et al.
Pageof 2